Robert Giugliano, MD

home / authors / robert-giugliano-md

Articles

Lipid-lowering Injectable Antibodies: The Next Big Thing?

Payal Kohli, MD;Robert Giugliano, MD

November 29th 2012

PCSK-9 inhibition in patients with recalcitrant hypercholesterolemia has reaped reductions in LDL-C of up to 85% after the first week of therapy.

Latest Updated Articles

An Asymptomatic Rash on the Low Back of an Older Woman

Published: July 22nd 2015 | Updated: March 31st 2025

An Asymptomatic Rash on the Low Back of an Older Woman

Roflumilast Foam 0.3% Significantly Reduces Pruritus and Improves Quality of Life in Scalp and Body Psoriasis

Published: March 7th 2025 | Updated: March 31st 2025

Roflumilast Foam 0.3% Significantly Reduces Pruritus and Improves Quality of Life in Scalp and Body Psoriasis

The Link Between Itch and Aging, with Daniel Butler, MD

Published: March 10th 2025 | Updated: March 31st 2025

The Link Between Itch and Aging, with Daniel Butler, MD

The Great Atopic Dermatitis Treatment Debate: Biologics vs JAK Inhibitors

Published: February 15th 2025 | Updated: March 31st 2025

The Great Atopic Dermatitis Treatment Debate: Biologics vs JAK Inhibitors

Brian S. Kim, MD: Why Primary Care Clinicians Should Prescribe New Treatments for Atopic Dermatitis

Published: March 10th 2025 | Updated: March 31st 2025

Brian S. Kim, MD: Why Primary Care Clinicians Should Prescribe New Treatments for Atopic Dermatitis

Atopic Dermatitis Breakthrough: Linda Stein Gold, MD, on Tapinarof's Treatment-Free Benefits

Published: March 9th 2025 | Updated: March 31st 2025

Atopic Dermatitis Breakthrough: Linda Stein Gold, MD, on Tapinarof's Treatment-Free Benefits

Editorial Board

Terms and Conditions

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.